FORWARD FEATURES CALENDAR

Funds

MCI.EuroVentures completes partial sale of Netrisk stake to TA Associates

Private equity firm MCI Group’s MCI.EuroVentures fund is selling a portion of its shares in Netrisk, an online insurance brokerage in Hungary, to global growth private equity firm TA Associates for EUR55 million (PLN 235 million). As a result of the partial exit, MCI.EuroVentures (buyout fund of MCI Group) has realised

Options secures significant growth investment from Abry Partners

Options, a provider of cloud-enabled managed services to the global capital markets, has secured a significant growth investment from Abry Partners, a Boston-based sector focused private equity firm. The transaction will enable the firm’s executive team to significantly accelerate its growth strategy, pursue strategic M&A targets, invest further in the firm’s technology

Varagon partners with Aflac Global Investments

Varagon Capital Partners, a direct lender to middle market companies, is to form a new strategic partnership with Aflac Global Investments (Aflac) and is extending its existing strategic partnership with American International Group (AIG).Upon closing of the new partnership, Aflac will make a new multi-year investment commitment of up to

MiAlgae secures GBP1 million investment

Edinburgh-based biotech startup MiAlgae has received an investment of GBP1 million to focus on the commercialisation of its revolutionary microalgae product, targeting the rapidly growing global aquaculture and pet food industries.The biotech business uses co-products from the whisky distillation process to produce microalgae, which is high in omega 3 and

Novo Seeds portfolio company NorthSea Therapeutics raises US40m in Series B financing

Novo Seeds’ portfolio company, NorthSea Therapeutics a Dutch biotech company developing novel and innovative strategies for the treatment of NASH (Non-alcoholic Steatohepatitis) and other metabolic, inflammatory and fibrotic diseases, has successfully closed a USD40 million (EUR36 million) Series B financing round.The proceeds of this fundraising will be used by NST

Shoreline Equity Partners raises USD300m for first private equity fund

Shoreline Equity Partners, a purpose-driven lower middle market private equity firm, has held the final close of its inaugural private equity fund, Shoreline Equity Partners Fund. Shoreline began fundraising in March, in conjunction with the Firm’s launch, with an initial target of USD250 million and was oversubscribed at its hard cap

OrganOx receives GBP4.6m investment from BGF

British MedTech business, OrganOx Ltd, has secured a GBP4.6 million investment from BGF, the UK and Ireland’s most active investor in growing businesses.The investment will fund commercial expansion of its first product, the metra, in the US, building on commercial traction in Europe, Canada and Australia.   OrganOx metra is

Events

12 November, 2026 – 5:00 pm

Directory Listings